跳至主要内容
临床试验/IRCT20100817004582N9
IRCT20100817004582N9招募中3 期

Investigating the efficacy of intracavernosal injection of platelet-rich plasma (PRP) in the treatment of erectile dysfunction in diabetic patients resistent to phosphodiesterase type 5 (PDE-5) inhibitors: a randomized controlled clinical trial

Guilan University of Medical Sciences0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
Male

入选标准

  • Non-responder to PDE5Is
  • Having score at least 21 in IIEF questionnair
  • More than 6 months have passed since erectile dysfunction
  • Have at least 10 years of diabets history
  • Having persistent sex in last 3 months

排除标准

  • History of using PDE5Is in the last month
  • History of psychological disorders and use of related drugs for its treatment
  • History ofusing energy therapy for erectile dysfunction in the last month
  • History of radiation or penile surgery or having penile prosthesis
  • History of trauma, fracture and pelvic surgery
  • History of priapism, penile fracture and Peyronie's
  • History of using anti-androgen and selective serotonin reuptake inhibitors (SSRIs)
  • Presence of active infection evidence in the injected area
  • Abnormal morning testosterone levels (lower than 200 and above 1197)

研究者

发起方
Guilan University of Medical Sciences

相似试验